Accord Urges Justices To Reject 'Crush-Resistant' Oxy IP Row

By Adam Lidgett · June 3, 2025, 5:55 PM EDT

Accord Healthcare Inc. says the U.S. Supreme Court should reject bankrupt OxyContin maker Purdue Pharma LP's attempt to revive its legal effort to use patent laws to block the release of...

To view the full article, register now.

Documents

Case Information

Case Title

Purdue Pharma L.P., et al., Petitioners v. Accord Healthcare, Inc.

Case Number

24-1132

Court

Supreme Court

Nature of Suit

835 Patent - (ANDA) (Fed. Qst.)

Date Filed

May 02, 2025